Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Present and future therapeutic strategies in non-alcoholic fatty liver disease.

Expert opinion on therapeutic targets - 1 Sept 2007

Calamita Giuseppe, Portincasa Piero

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is found in individuals who do not drink or abuse alcohol and represents a significant health burden for the general community. NAFLD is often associated with one or more features of the metabolic syndrome and has potential for evolution towards non-alcoholic steatohepatitis (NASH), the necro-inflammatory form of liver steatosis. The most worrisome evolutive events in a...

Topics

Join the communities discussing this publication.

Fatty Liver
Genomics
Genotype
Insulin Resistance
Metabolic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17845148
DOI: 10.1517/14728222.11.9.1231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Present and future therapeutic strategies in non-alcoholic fatty liver disease.PMID 17845148Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Non-alcoholic Fatty Liver Disease (NAFLD) Management in the CommunitySemantic proximity Read ↗

[Pathogenesis of non-alcoholic fatty liver disease].Semantic proximity Read ↗

Obesity and the liver: nonalcoholic fatty liver disease.Semantic proximity Read ↗

Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.Semantic proximity Read ↗

Nonalcoholic fatty liver disease.Semantic proximity Read ↗

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.